IL97399A0 - Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same - Google Patents

Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same

Info

Publication number
IL97399A0
IL97399A0 IL97399A IL9739991A IL97399A0 IL 97399 A0 IL97399 A0 IL 97399A0 IL 97399 A IL97399 A IL 97399A IL 9739991 A IL9739991 A IL 9739991A IL 97399 A0 IL97399 A0 IL 97399A0
Authority
IL
Israel
Prior art keywords
cloning
production
methods
binding domain
same
Prior art date
Application number
IL97399A
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of IL97399A0 publication Critical patent/IL97399A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL97399A 1990-03-02 1991-03-03 Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same IL97399A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48776790A 1990-03-02 1990-03-02

Publications (1)

Publication Number Publication Date
IL97399A0 true IL97399A0 (en) 1992-06-21

Family

ID=23937035

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97399A IL97399A0 (en) 1990-03-02 1991-03-03 Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same

Country Status (10)

Country Link
EP (1) EP0517826A4 (en)
JP (1) JPH05506646A (en)
CA (1) CA2077446A1 (en)
FI (1) FI923935A (en)
HU (1) HU216066B (en)
IL (1) IL97399A0 (en)
NO (1) NO923410L (en)
NZ (1) NZ237244A (en)
RU (1) RU2109816C1 (en)
WO (1) WO1991013093A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900476A (en) * 1986-05-30 1999-05-04 The Scripps Research Institute Therapeutic domains of van Willebrand factor
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
FR2686901A1 (en) * 1992-01-31 1993-08-06 Rhone Poulenc Rorer Sa NOVEL ANTITHROMBOTIC POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
WO1994018225A1 (en) * 1993-02-11 1994-08-18 The Du Pont Merck Pharmaceutical Company 15-oxasterols as hypocholesterolemics
ZA942818B (en) * 1993-04-23 1995-01-30 Bio Technology General Corp Method of enhancing thrombolysis.
AT405403B (en) 1997-02-27 1999-08-25 Immuno Ag CLEANING OF WILLEBRAND FACTOR BY CATION EXCHANGER CHROMATOGRAPHY
AT406373B (en) 1997-02-27 2000-04-25 Immuno Ag METHOD FOR CLEANING FACTOR VIII / VWF COMPLEX BY CATION EXCHANGER CHROMATOGRAPHY
AT408443B (en) * 1998-02-27 2001-11-26 Immuno Ag METHOD FOR OBTAINING PURIFIED FACTOR VIII: C / VWF COMPLEX
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
DE102007031708A1 (en) 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Determination of von Willebrand factor activity in the absence of ristocetin
CN102459599A (en) * 2009-06-03 2012-05-16 雷加多生物科学公司 Nucleic acid modulators of glycoprotein vi
GB201707139D0 (en) * 2017-05-04 2017-06-21 Imp Innovations Ltd Polypeptides
CN110624105B (en) * 2019-09-24 2021-06-11 苏州大学 Sequences of structurally sensitive polypeptide antigens of von Willebrand factor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
DE3751179T2 (en) * 1986-05-30 1995-07-27 Scripps Research Inst Peptides that inhibit the binding of the Von Willebrand factor.

Also Published As

Publication number Publication date
FI923935A0 (en) 1992-09-02
RU2109816C1 (en) 1998-04-27
NO923410D0 (en) 1992-09-01
AU7496491A (en) 1991-09-18
HU9202821D0 (en) 1992-11-30
WO1991013093A1 (en) 1991-09-05
HUT63183A (en) 1993-07-28
HU216066B (en) 1999-04-28
AU645077B2 (en) 1994-01-06
NZ237244A (en) 1992-10-28
FI923935A (en) 1992-09-02
JPH05506646A (en) 1993-09-30
EP0517826A4 (en) 1993-05-26
NO923410L (en) 1992-10-26
CA2077446A1 (en) 1991-09-03
EP0517826A1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
DE68928033T2 (en) STEREOSYNTHESIZER AND CORRESPONDING PROCEDURE
ZA913291B (en) Hair-treating microemulsion composition and method of preparing and using the same
GB2243956B (en) Electrical resistors and methods of making same
IL97399A0 (en) Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same
DE59302386D1 (en) USE OF POLYCONDENSATE AND NEW POLYCONDENSATE
DE4393944T1 (en) Use of ecdysteroids in cosmetics and dermatology
GB9013410D0 (en) Polypeptide and its use
DE69214283T2 (en) USE OF CELLULASE IN CELLULAR TREATMENT
RO105577B1 (en) Plastomerical polyolefinic composition and preparation precess thereof
ZA902344B (en) Substituted isoquinolines and methods of using same
IL88308A0 (en) Peptides that block the binding of von willebrand factor
GB2164044B (en) -hanp related polypeptides and their use
DK62589D0 (en) CLONING AND EXPRESSION OF HUMAN GROWTH FACTOR
PL288761A1 (en) Method of obtaining novel polypeptides
AU2645588A (en) The von willebrand factor binding domain of factor viii
ZA917009B (en) Polyethylene terephthalate compositions and methods of using thereof
NO174731C (en) Anti-microbial composition and use thereof
DE69524590D1 (en) COMPOSITION OF 5HTIDA AND 5HTID ANTAGONISTS
GB9126918D0 (en) Members of specific binding pairs;methods of their making and using
EP0473419A3 (en) Voltage non-linear resistor and method of producing the same
IL88880A (en) Preparation of halopyridine intermediates and some such novel compounds
NO914919L (en) NICKEL-BASED SUPPLIED AND USE OF THIS
EP0459788A3 (en) Modified proteins and methods of producing same
DK299889D0 (en) CLONING AND EXPRESSION OF HUMAN TISSUE FACTOR
EP0407543A4 (en) Mammalian gap-43 compositions and methods of use